Triheptanoin
id:
triheptanoin-302-9954798
title:
Triheptanoin
text:
Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea. Triheptanoin was approved for medical use in the United States in June 2020. Triheptanoin is a triglyceride that is composed of three seven-carbon (C7:0) fatty acids. These odd-carbon fatty acids are able to provide anaplero
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Triheptanoin
date created:
date modified:
2024-03-13T19:48:03Z
main entity:
{"identifier":"Q414576","url":"https://www.wikidata.org/entity/Q414576"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fb/Triheptanoin.svg","width":512,"height":516}
fields total:
13
integrity:
15